In conclusion, our results of increased plasma Lp-PLA2 activity in patients with the metabolic syndrome, especially in those with carotid atherosclerosis, suggest that Lp-PLA2 may be an inflammatory marker of metabolic syndrome. This evidence concerns the gene PLA2G7 and metabolic syndrome.